A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival
2001/08/01 by Michel Lacroix, Dima Abi-Said, Daryl R. Fourney +14 · 3,094 citations
Medicine · #Brain Metastases and Treatment #Central nervous system disease #Confidence interval #Glioblastoma #Glioma Diagnosis and Treatment #Internal medicine #Magnetic resonance imaging #Medicine #Meningioma and schwannoma management #Multivariate analysis #Radiology #Resection #Surgery #Survival analysis
paper · doi:10.3171/jns.2001.95.2.0190
published in Journal of neurosurgery 95(2), 190-198 (American Association of Neurological Surgeons)
openalex publication_date 2001/08/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/05
Abstract
OBJECT: The extent of tumor resection that should be undertaken in patients with glioblastoma multiforme (GBM) remains controversial. The purpose of this study was to identify significant independent predictors of survival in these patients and to determine whether the extent of resection was associated with increased survival time. METHODS: The authors retrospectively analyzed 416 consecutive patients with histologically proven GBM who underwent tumor resection at the authors' institution between June 1993 and June 1999. Volumetric data and other tumor characteristics identified on magnetic resonance (MR) imaging were collected prospectively. CONCLUSIONS: Five independent predictors of survival were identified: age, Karnofsky Performance Scale (KPS) score, extent of resection, and the degree of necrosis and enhancement on preoperative MR imaging studies. A significant survival advantage was associated with resection of 98% or more of the tumor volume (median survival 13 months, 95% confidence interval [CI] 11.4-14.6 months), compared with 8.8 months (95% CI 7.4-10.2 months; p < 0.0001) for resections of less than 98%. Using an outcome scale ranging from 0 to 5 based on age, KPS score, and tumor necrosis on MR imaging, we observed significantly longer survival in patients with lower scores (1-3) who underwent aggressive resections, and a trend toward slightly longer survival was found in patients with higher scores (4-5). Gross-total tumor resection is associated with longer survival in patients with GBM, especially when other predictive variables are favorable.
Cited by
- Continuous dynamic mapping of the corticospinal tract during surgery of motor eloquent brain tumors: evaluation of a new method
- An extent of resection threshold for newly diagnosed glioblastomas
- Novel approaches to targeting gliomas at the leading/cutting edge
- Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research
- The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma
- Outcome Prediction in Patients with Glioblastoma by Using Imaging, Clinical, and Genomic Biomarkers: Focus on the Nonenhancing Component of the Tumor
- Intraoperative High-Field-Strength MR Imaging: Implementation and Experience in 200 Patients
- Hypoxic Cell Waves Around Necrotic Cores in Glioblastoma: A Biomathematical Model and Its Therapeutic Implications
- Supratotal resection of diffuse gliomas – an overview of its multifaceted implications
- Glioblastoma Multiforme Segmentation in MRI Data with a Balloon Inflation Approach
- Evaluation of a Novel Approach for Automatic Volume Determination of Glioblastomas Based on Several Manual Expert Segmentations
- Ten-year survival in glioblastoma. A systematic review
- Hypoxic Cell Waves around Necrotic Cores in Glioblastoma: A Biomathematical Model and its Therapeutic Implications
- Histology and spatial transcriptomic integration revealed infiltration zone with specific cell composition as a prognostic hotspot in glioblastoma
- EANS-EANO guidelines on the extent of resection in gliomas
- Standardisation of the radiological definition of supramaximal resection in glioblastoma
- In vivo solid stress is associated with poor patient survival in glioma
- A Comparison of Two Human Brain Tumor Segmentation Methods for MRI Data
- Framework for Statistical Parametric Mapping of the Interactions between Glioblastoma Location, Treatment, Prognostic Variables, and Survival Using a Phase III Trial
- Wide-Field Mueller Polarimetry of Brain Tissue Sections for Visualization of White Matter Fiber Tracts
- Craniotomy and Survival for Primary Central Nervous System Lymphoma
- Angiogenesis in gliomas: biology and molecular pathophysiology. [europepmc]
- Classification of brain tumor type and grade using MRI texture and shape in a machine learning scheme. [europepmc]
- Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. [europepmc]
- Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article. [europepmc]
- Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain. [europepmc]
- Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. [europepmc]
- Improved survival time trends for glioblastoma using the SEER 17 population-based registries. [europepmc]
- Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma. [europepmc]
- Ambient mass spectrometry for the intraoperative molecular diagnosis of human brain tumors. [europepmc]
- Rapid, label-free detection of brain tumors with stimulated Raman scattering microscopy. [europepmc]
- A randomized trial of bevacizumab for newly diagnosed glioblastoma. [europepmc]
- Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor. [europepmc]
- Epidemiologic and molecular prognostic review of glioblastoma. [europepmc]
- Detection of human brain cancer infiltration ex vivo and in vivo using quantitative optical coherence tomography. [europepmc]
- Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis. [europepmc]
- Glioblastoma: Overview of Disease and Treatment. [europepmc]
- Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings. [europepmc]
- Beyond the margins: real-time detection of cancer using targeted fluorophores. [europepmc]
- Advances in Brain Tumor Surgery for Glioblastoma in Adults. [europepmc]
- Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014. [europepmc]
- 5-ALA and FDA approval for glioma surgery. [europepmc]
- Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation. [europepmc]
- Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma. [europepmc]
- Current FDA-Approved Therapies for High-Grade Malignant Gliomas. [europepmc]
- Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance. [europepmc]
Related